Influenza vaccine safety in children less than 5 years old: The 2010 and 2011 experience in Australia

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 199-202

  Wood, Nicholas ^a,b,c   Sheppeard, Vicky ^d   Cashman, Patrick ^e   Palasanthiran, Pamela ^f,g   Casacelli, Margot ^f   Cannings, Kathryn ^a,b   Mcintyre, Peter ^a,b,c  

^a NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Centre for Population Health   (Australia)

^e Population Health   (Australia)

^f SYDNEY CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Convulsion children; Fever; Influenza vaccine

Indexed keywords

INFLUENZA VACCINE; TRIVALENT INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; CHILD; DRUG SAFETY; FEBRILE CONVULSION; FEMALE; FEVER; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

AUSTRALIA; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE;

EID: 84858153320     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31823d5303     Document Type: Article

References (17)

1. Department of Health and Ageing, Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination: status report as at 2 July 2010. Canberra, Australia: TGA; 2010. Available at: http://www.tga.gov.au/safety/alerts- medicine-seasonal-flu-100702.htm#fullreport. Updated September 24, 2010. Accessed May 2011.
2. Hambridge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296:1990-1997. (Pubitemid 44631445)
3. France EK, Glanz JM, Xu S, et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004;158:1031-1036. (Pubitemid 39458490)
4. Rosenberg M, Sparks R, McMahon A, et al. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. Vaccine. 2009;27:4278-4283.
5. McMahon AW, Iskander J, Haber P, et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics. 2005;115:453-460. (Pubitemid 43193830)
6. NHMRC (National Health and Medical Research Council). The Australian Immunisation Handbook. 9th ed. Canberra, Australian Capital Territory: Australian Government Department of Health and Ageing; 2008. Available at: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home. Accessed August 2, 2011.
7. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morb Mortal Wkly Rep. 2010; 59(RR-8).
8. Australian Government. Department of Health and Ageing. Seasonal flu vaccine and young children. April 23, 2010. Media Release. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/ mryr10-dept-dept230410.htm.
9. Armstrong PK, Dowse GK, Effler PV, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ. In press.
10. Blyth CC, Currie AJ, Wiertsema SP, et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine. 2011;29:5107-5113.
11. Petoussis-Harris H, Poole T, Booy R, et al. Fever following administration of two inactivated influenza vaccines - a survey of parents of New Zealand infants and children 5 years of age and under. Vaccine. 2011;29:2933-2977.
12. Update: recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States During 2010-11. Weekly. August 13, 2010;59(31): 989-992. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5931a4.htm. Accessed August 7, 2011.
13. Department of Health and Aging; Australian Technical Advisory Group on Immunisation (ATAGI) Statement. Clinical advice for immunisation providers regarding the administration of 2011 trivalent seasonal influenza vaccines. March 2011. Canberra, Australia: Government of Australia; 2011. Available at: http://www.immunise.health.gov.au/internet/immunise/Publishing.nsf/content/ immunise-atagi-vaccine-advice. Cited August 2, 2011.
14. Blyth CC, Markus TY, Effler PV, et al. Ensuring safety of the 2011 trivalent influenza vaccine in young children. Med J Aust. 2011;195:52.
15. Skowronski D, Hottes T, Chong M, et al. Randomized control trial of dose response to influenza vaccine in children aged 6 to 23 months. Paediatrics. 2011;128:e276-e289.
16. Gold MS, Effler P, Kelly H, et al. Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia. Med J Aust. 2010;193:492-493.
17. Kelly H, Carcione D, Dowse G, et al. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveill. 2010;15:pii-19661.